We are live on
!
Find out more
Lexicon Pharmaceuticals
LXRX
LXRX
123 hedge funds and large institutions have $626M invested in Lexicon Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 47 increasing their positions, 19 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
154% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 13
147% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 19
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
18% more funds holding
Funds holding: 104 → 123 (+19)
5% less capital invested
Capital invested by funds: $657M → $626M (-$31.1M)
Holders
123
Holders Change
+19
Holders Change %
+18.27%
% of All Funds
3.28%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
33
Increased
47
Reduced
19
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AG
Artal Group
Luxembourg
|
+$172M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$34.4M |
| 3 |
UBS AM
Chicago,
Illinois
|
+$12.6M |
| 4 |
MCM
Masters Capital Management
Atlanta,
Georgia
|
+$9.21M |
| 5 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$5.76M |
Top Sellers
| 1 |
Norges Bank
Oslo,
Norway
|
-$1.51M |
| 2 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$164K |
| 3 |
GF
Gabelli Funds
Rye,
New York
|
-$116K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$111K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$100K |
